Posted On: 11/19/2013 8:08:02 AM
Post# of 72446
Even our "buddy" NOretreat is getting bashed on iFlub by the stooges (58cabbie) for this realistic assessment. Those animals will eat their own over there . . . sad!
noretreat Tuesday, 11/19/13 06:40:46 AM
Re: None
Post # of 46341
Random notes on CTIX...
Regarding Prurisol...To me it sounds like they are consistently WAITING on Dr. Reddy's to provide them with something they need (or perhaps blaming them for the delay). We had a fairly long period earlier where we were WAITING for Dr. Reddy's to streamline the manufacturing process . That stopped the POC from happening during the first 6 months of this year.
These PR's are getting about as exciting as some of the ones from NNVC. I don't know how much I like it when Dr. Menon states that there are things in the asset purchase that he didn't expect. That is almost certainly double-edged.
No Matter!
Share price soft on relatively high volume looks to me like Aspire selling timed with whatever PR they can come up with. They need a lot more cash now so the medium term outlook without K results is changing.
An decent antibiotic partnership won't even be possible until 2b is complete, and to me it would be better to wait until 3 is complete....but at least a year. Anything before that will likely be lousy terms. I expect nothing out of the upcoming conference , but I would like to see the presentation.....
The only way out of the share price doldrums continues to be Kevetrin, and that result could be next year at this time.
noretreat Tuesday, 11/19/13 06:40:46 AM
Re: None
Post # of 46341
Random notes on CTIX...
Regarding Prurisol...To me it sounds like they are consistently WAITING on Dr. Reddy's to provide them with something they need (or perhaps blaming them for the delay). We had a fairly long period earlier where we were WAITING for Dr. Reddy's to streamline the manufacturing process . That stopped the POC from happening during the first 6 months of this year.
These PR's are getting about as exciting as some of the ones from NNVC. I don't know how much I like it when Dr. Menon states that there are things in the asset purchase that he didn't expect. That is almost certainly double-edged.
No Matter!
Share price soft on relatively high volume looks to me like Aspire selling timed with whatever PR they can come up with. They need a lot more cash now so the medium term outlook without K results is changing.
An decent antibiotic partnership won't even be possible until 2b is complete, and to me it would be better to wait until 3 is complete....but at least a year. Anything before that will likely be lousy terms. I expect nothing out of the upcoming conference , but I would like to see the presentation.....
The only way out of the share price doldrums continues to be Kevetrin, and that result could be next year at this time.
(0)
(0)
